1
Clinical Trials associated with Nesiritide(Chengdu Shengnuo Biopharm) [Translation] Tolerability and pharmacokinetic studies
观察奈西立肽静脉给药后健康受试者的耐受性和安全性,并根据临床药代动力学研究,制定本品的Ⅱ期临床试验给药方案,提供安全的推荐剂量。
[Translation] Observe the tolerability and safety of healthy subjects after intravenous administration of nesiritide, and formulate a dosing regimen for the Phase II clinical trial of this product based on clinical pharmacokinetic studies to provide a safe recommended dose.
Start Date- |
Sponsor / Collaborator- |
100 Clinical Results associated with Nesiritide(Chengdu Shengnuo Biopharm)
100 Translational Medicine associated with Nesiritide(Chengdu Shengnuo Biopharm)
100 Patents (Medical) associated with Nesiritide(Chengdu Shengnuo Biopharm)
100 Deals associated with Nesiritide(Chengdu Shengnuo Biopharm)